These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31654945)

  • 1. Modeling the conformations of Neisseria meningitidis serogroup a CPS and a carba-analogue: Implications for vaccine development.
    Hlozek J; Ravenscroft N; Kuttel MM
    Carbohydr Res; 2019 Dec; 486():107838. PubMed ID: 31654945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformations of Neisseria meningitidis serogroup A and X polysaccharides: The effects of chain length and O-acetylation.
    Hlozek J; Kuttel MM; Ravenscroft N
    Carbohydr Res; 2018 Jul; 465():44-51. PubMed ID: 29940397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoactivity of protein conjugates of carba analogues from Neisseria meningitidis a capsular polysaccharide.
    Gao Q; Tontini M; Brogioni G; Nilo A; Filippini S; Harfouche C; Polito L; Romano MR; Costantino P; Berti F; Adamo R; Lay L
    ACS Chem Biol; 2013 Nov; 8(11):2561-7. PubMed ID: 24000773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines.
    Tunheim G; Arnemo M; Næss LM; Fjeldheim ÅK; Nome L; Bolstad K; Aase A; Mandiarote A; González H; González D; García L; Cardoso D; Norheim G; Rosenqvist E
    Vaccine; 2013 Dec; 31(51):6097-106. PubMed ID: 24120679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-protection in Neisseria meningitidis serogroups Y and W polysaccharides: A comparative conformational analysis.
    Kuttel MM; Timol Z; Ravenscroft N
    Carbohydr Res; 2017 Jun; 446-447():40-47. PubMed ID: 28501716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of a protective epitope reveals the importance of acetylation of
    Henriques P; Dello Iacono L; Gimeno A; Biolchi A; Romano MR; Arda A; Bernardes GJL; Jimenez-Barbero J; Berti F; Rappuoli R; Adamo R
    Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29795-29802. PubMed ID: 33158970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Conformation of the Mannopyranosyl Phosphate Repeating Unit of the Capsular Polysaccharide of
    Calloni I; Unione L; Jiménez-Osés G; Corzana F; Del Bino L; Corrado A; Pitirollo O; Colombo C; Lay L; Adamo R; Jiménez-Barbero J
    European J Org Chem; 2018 Sep; 2018(33):4548-4555. PubMed ID: 30443159
    [No Abstract]   [Full Text] [Related]  

  • 8. Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.
    Xie O; Pollard AJ; Mueller JE; Norheim G
    Vaccine; 2013 Jun; 31(27):2852-61. PubMed ID: 23623866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neisseria meningitidis serogroup C polysaccharide and serogroup B outer membrane vesicle conjugate as a bivalent meningococcus vaccine candidate.
    Fukasawa LO; Gorla MC; Schenkman RP; Garcia LR; Carneiro SM; Raw I; Tanizaki MM
    Vaccine; 1999 Aug; 17(23-24):2951-8. PubMed ID: 10462229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of each serogroup polysaccharide of Neisseria meningitidis in A/C/Y/W-135-DT conjugate vaccine by high-performance anion-exchange chromatography-pulsed amperometric detection analysis.
    Gudlavalleti SK; Crawford EN; Harder JD; Reddy JR
    Anal Chem; 2014 Jun; 86(11):5383-90. PubMed ID: 24810004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and preliminary biological evaluation of carba analogues from Neisseria meningitidis A capsular polysaccharide.
    Gao Q; Zaccaria C; Tontini M; Poletti L; Costantino P; Lay L
    Org Biomol Chem; 2012 Sep; 10(33):6673-81. PubMed ID: 22850927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative proton nuclear magnetic resonance evaluation and total assignment of the capsular polysaccharide Neisseria meningitidis serogroup X.
    Garrido R; Puyada A; Fernández A; González M; Ramírez U; Cardoso F; Valdés Y; González D; Fernández V; Vérez V; Vélez H
    J Pharm Biomed Anal; 2012 Nov; 70():295-300. PubMed ID: 22877873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four monoclonal antibodies against capsular polysaccharides of Neisseria meningitidis serogroups A, C, Y and W135: its application in identity tests.
    Reyes F; Amin N; Otero O; Aguilar A; Cuello M; Valdés Y; García LG; Cardoso D; Camacho F
    Biologicals; 2013 Jul; 41(4):275-8. PubMed ID: 23791517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative stability of meningococcal serogroup A and X polysaccharides.
    Berti F; Romano MR; Micoli F; Pinto V; Cappelletti E; Gavini M; Proietti D; Pluschke G; MacLennan CA; Costantino P
    Vaccine; 2012 Oct; 30(45):6409-15. PubMed ID: 22921741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermostable formulations of a hepatitis B vaccine and a meningitis A polysaccharide conjugate vaccine produced by a spray drying method.
    Chen D; Kapre S; Goel A; Suresh K; Beri S; Hickling J; Jensen J; Lal M; Preaud JM; Laforce M; Kristensen D
    Vaccine; 2010 Jul; 28(31):5093-9. PubMed ID: 20478345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges for the development of vaccines against Haemophilus influenzae and Neisseria meningitidis.
    Cripps AW; Foxwell R; Kyd J
    Curr Opin Immunol; 2002 Oct; 14(5):553-7. PubMed ID: 12183152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technical Development of a New Meningococcal Conjugate Vaccine.
    Frasch CE; Kapre SV; Lee CH; Préaud JM
    Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S404-9. PubMed ID: 26553667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A stabilized glycomimetic conjugate vaccine inducing protective antibodies against Neisseria meningitidis serogroup A.
    Enotarpi J; Tontini M; Balocchi C; van der Es D; Auberger L; Balducci E; Carboni F; Proietti D; Casini D; Filippov DV; Overkleeft HS; van der Marel GA; Colombo C; Romano MR; Berti F; Costantino P; Codeé JDC; Lay L; Adamo R
    Nat Commun; 2020 Sep; 11(1):4434. PubMed ID: 32895393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines against polysaccharide antigens.
    Lesinski GB; Westerink MA
    Curr Drug Targets Infect Disord; 2001 Nov; 1(3):325-34. PubMed ID: 12455405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biosynthesis of Conjugate Vaccines Using an O-Linked Glycosylation System.
    Pan C; Sun P; Liu B; Liang H; Peng Z; Dong Y; Wang D; Liu X; Wang B; Zeng M; Wu J; Zhu L; Wang H
    mBio; 2016 Apr; 7(2):e00443-16. PubMed ID: 27118590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.